On Invalid Date, Catheter Precision (NYSEMKT: VTAK) reported Q1 2024 earnings per share (EPS) of -$0.36, up 98.54% year over year. Total Catheter Precision earnings for the quarter were -$2.68 million. In the same quarter last year, Catheter Precision's earnings per share (EPS) was -$24.65.
As of Q2 2024, Catheter Precision's earnings has grown year over year. Catheter Precision's earnings in the past year totalled -$6.85 million.
What is VTAK's earnings date?
Catheter Precision's earnings date is Invalid Date. Add VTAK to your watchlist to be reminded of VTAK's next earnings announcement.
What was VTAK's revenue last quarter?
On Invalid Date, Catheter Precision (NYSEMKT: VTAK) reported Q1 2024 revenue of $82.00 thousand up 3.53% year over year. In the same quarter last year, Catheter Precision's revenue was $85.00 thousand.
What was VTAK's revenue growth in the past year?
As of Q2 2024, Catheter Precision's revenue has grown 387.78% year over year. This is 377.08 percentage points higher than the US Medical Devices industry revenue growth rate of 10.69%. Catheter Precision's revenue in the past year totalled $439.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.